Adults 18 to 60, female only, with Opioid-use Disorder. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
SUD Symptoms - Mini Neuropsychiatric InterviewSecondary· 8 weeks
The Mini Neuropsychiatric Interview is a brief structured diagnostic interview for the major psychiatric disorders in the DSM-V. For this study, we conducted a structured interview with participants to determine the number of symptoms of substance use disorder they had experienced in the past year. After completing eight sessions of Mindfulness-Oriented Recovery Enhancement, we conducted the same interview to learn the number of symptoms of substance use disorder participants had experienced in the past eight weeks.
Group
Value
95% CI
Mindfulness-Oriented Recovery Enhancement Via Tele-health
12
Sponsor's own description
Thirty pregnant women with substance use disorder will be recruited to participate in eight sessions of MORE.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Other trials of Mindfulness-Oriented Recovery Enhancement
Trials testing the same drug.
NCT05537961 — Impact of Mindfulness Training on Adolescent Well-Being and Behavior
· NA
· completed
NCT04902339 — Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With C
· NA
· completed
NCT03298269 — Behavioral Interventions for Chronic Pain and Opioid-Related Problems
· NA
· completed
Other recruiting trials for Opioid-use Disorder
Currently open trials in the same condition.
NCT04783558 — Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk
· NA
· active not recruiting
NCT05011266 — Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
· Phase 2, PHASE3
· recruiting
NCT05039554 — Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment
· NA
· recruiting
NCT04738825 — Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With Pr
· NA
· recruiting
Other University of Montana trials
Trials by the same sponsor.
NCT06960759 — Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
· Phase 2
· not yet recruiting
NCT07254689 — The Food for Health Study
· NA
· recruiting
NCT06887647 — Physical Therapy for Montana Children With NMD Using Hippotherapy and the Equine Environment
· NA
· recruiting
NCT06788145 — Enhancing Social Connections Among Rural Community Members With Disordered Eating
· NA
· not yet recruiting
NCT05763537 — Understanding the Role of Doulas in Supporting People With PMADs
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Montana
Last refreshed: 16 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04824521.